Income Statement
LIFECORE BIOMEDICAL, INC. DE
LFCR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | May 31, 2025 2025 FY | May 31, 2024 2024 FY | May 31, 2023 2023 FY | May 31, 2022 2022 FY | May 31, 2021 2021 FY | May 31, 2020 2020 FY | May 31, 2019 2019 FY | May 31, 2018 2018 FY | May 31, 2017 2017 FY | May 31, 2016 2016 FY | May 31, 2015 2015 FY | May 31, 2014 2014 FY | May 31, 2013 2013 FY | May 31, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | 524.23 | - | - | - | - | 441.71 | 317.55 |
|
Cost of Revenue
|
88.57 | 86.41 | 75.28 | 135.42 | 462.69 | 515.38 | 476.56 | 445.89 | - | - | - | - | 378.95 | 265.41 |
|
Gross Profit
|
40.30 | 41.85 | 27.99 | 50.37 | 81.47 | 74.99 | 81.00 | 78.34 | 83.19 | 70.96 | 65.41 | 62.56 | 62.76 | 52.14 |
|
Operating Expenses
|
52.30 | 50.69 | 49.78 | 91.66 | 94.97 | 113.53 | 75.53 | 64.75 | 67.68 | 90.74 | 46.95 | 42.37 | 37.89 | 37.56 |
|
Research & Development
|
8.26 | 8.58 | 8.74 | 7.84 | 10.22 | 11.10 | 11.47 | 12.80 | 9.47 | 7.23 | 6.99 | 7.20 | 9.29 | 9.63 |
|
Selling, General & Administrative
|
44.05 | 40.46 | 38.97 | 46.13 | 65.36 | 72.19 | 64.06 | 51.95 | 55.63 | 49.52 | 39.96 | 35.17 | 32.53 | 26.52 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-12.01 | -8.84 | -21.80 | -41.29 | -13.50 | -38.54 | 5.48 | 13.59 | 15.51 | -19.79 | 18.46 | 20.19 | 24.87 | 14.58 |
|
Non-Operating Income
|
26.67 | -18.36 | 42.13 | 10.82 | 26.97 | 12.77 | 1.84 | -2.81 | 0.49 | - | - | - | -7.40 | -5.71 |
|
Interest Income
|
- | - | 0.07 | 0.08 | 0.05 | 0.10 | 0.15 | 0.21 | 0.02 | 0.07 | 0.32 | 0.26 | 0.18 | 0.18 |
|
Interest Expense
|
21.84 | - | 17.65 | 17.36 | - | - | - | - | - | 1.99 | 1.83 | 1.65 | 2.01 | 0.93 |
|
Other Non-Op Income / Expense
|
0.00 | -3.05 | -1.16 | 0.64 | -11.69 | -4.40 | 1.60 | 2.90 | 0.90 | 1.20 | 3.11 | 10.00 | 8.10 | 5.33 |
|
Income Before Tax
|
-38.67 | 9.51 | -63.93 | -52.12 | -40.47 | -51.31 | 3.64 | 16.40 | 15.01 | - | - | - | 32.26 | 20.28 |
|
Income Tax Expense
|
0.04 | -2.50 | 35.64 | 45.32 | -7.80 | -13.12 | 3.23 | -8.43 | 4.42 | - | - | - | 9.68 | 7.59 |
|
Non-Controlling Interest
|
- | - | - | - | - | 0.00 | 0.00 | 0.09 | 0.09 | 0.19 | 0.18 | 0.20 | 0.23 | 0.40 |
|
Net Income
|
-38.72 | 12.01 | -99.56 | -97.43 | -32.67 | -38.19 | 0.41 | 24.83 | 10.59 | -31.98 | 17.15 | 19.15 | 22.59 | 12.70 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | May 31, 2025 2025 FY | May 31, 2024 2024 FY | May 31, 2023 2023 FY | May 31, 2022 2022 FY | May 31, 2021 2021 FY | May 31, 2020 2020 FY | May 31, 2019 2019 FY | May 31, 2018 2018 FY | May 31, 2017 2017 FY | May 31, 2016 2016 FY | May 31, 2015 2015 FY | May 31, 2014 2014 FY | May 31, 2013 2013 FY | May 31, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-3.98 | 0.02 | -8.51 | -23.41 | 6.37 | -19.70 | 20.71 | 26.00 | 26.18 | -10.39 | 25.55 | 27.30 | 32.16 | 20.20 |
|
Earnings Per Share (Basic)
|
-1.27 | 0.40 | -3.32 | -3.31 | -1.12 | -1.31 | 0.01 | 0.90 | 0.39 | -0.43 | 0.50 | 0.72 | 0.87 | 0.49 |
|
Diluted EPS
|
-1.27 | 0.32 | -3.32 | -3.31 | -1.12 | -1.31 | 0.01 | 0.89 | 0.38 | -0.43 | 0.50 | 0.71 | 0.85 | 0.49 |
|
Weighted Average Shares
|
34.82 | 30.47 | 29.96 | 29.47 | 29.29 | 29.16 | 28.36 | 27.54 | 27.28 | 27.04 | 0.03 | 26.63 | 25.83 | 0.03 |
|
Diluted Weighted Avg Shares
|
34.82 | 36.66 | 29.96 | 29.47 | 29.29 | 29.16 | 28.61 | 27.92 | 27.65 | 27.04 | 0.03 | 27.12 | 26.63 | 0.03 |
|
Comprehensive Income
|
- | 12.01 | -98.98 | -96.66 | -31.22 | -41.06 | - | - | - | -11.64 | 13.54 | 19.15 | - | - |